Inhibition of β - catenin/TCF by ICG - 001 combined with TGF - β 1 treatment increased β-catenin/Foxo1 and reduced MMT and inflammatory cytokine production in bone marrow-derived macrophages, thereby attenuating renal fibrosis in the UUO model. Here, FOXO1 is linked to renal fibrosis.